MFW
IDXX icon

Meristem Family Wealth’s Idexx Laboratories IDXX Stock Holding History

Meristem Family Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-934
Closed -$457K – 327
2021
Q1 		$457K Hold
934
– – 0.09% 135
2020
Q4 		$467K Buy
+934
New +$418K 0.1% 130

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Meristem Family Wealth's IDXX Position: Q2 2021 in Review

Meristem Family Wealth sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 934 shares — an estimated $457K sold.

Meristem Family Wealth first reported a position in IDXX in Q4 2020 and held it in 2 quarters. The position peaked at $467K in Q4 2020. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

  • Meristem Family Wealth reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
  • Meristem Family Wealth sold 934 Idexx Laboratories shares in Q2 2021, an estimated $457K.
  • Meristem Family Wealth first reported a position in Idexx Laboratories in Q4 2020 and held it in 2 quarters.
  • Meristem Family Wealth's Idexx Laboratories position peaked at $467K in Q4 2020.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Meristem Family Wealth's 13F filing for Q2 2021, filed 6 Aug 2021.